1. Home
  2. EXPO vs ALKS Comparison

EXPO vs ALKS Comparison

Compare EXPO & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exponent Inc.

EXPO

Exponent Inc.

HOLD

Current Price

$72.33

Market Cap

3.6B

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$28.53

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXPO
ALKS
Founded
1967
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6B
4.7B
IPO Year
1990
1991

Fundamental Metrics

Financial Performance
Metric
EXPO
ALKS
Price
$72.33
$28.53
Analyst Decision
Buy
Strong Buy
Analyst Count
2
13
Target Price
$81.00
$42.85
AVG Volume (30 Days)
473.8K
1.9M
Earning Date
02-05-2026
10-28-2025
Dividend Yield
1.67%
N/A
EPS Growth
N/A
2.44
EPS
2.03
2.02
Revenue
$531,142,000.00
$1,521,338,000.00
Revenue This Year
$5.31
N/A
Revenue Next Year
$7.93
$24.22
P/E Ratio
$35.48
$14.10
Revenue Growth
4.43
1.08
52 Week Low
$63.81
$25.17
52 Week High
$97.57
$36.45

Technical Indicators

Market Signals
Indicator
EXPO
ALKS
Relative Strength Index (RSI) 50.72 46.34
Support Level $70.32 $27.69
Resistance Level $75.01 $28.53
Average True Range (ATR) 1.75 0.85
MACD -0.09 -0.03
Stochastic Oscillator 32.28 42.22

Price Performance

Historical Comparison
EXPO
ALKS

About EXPO Exponent Inc.

Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: